Abstract:The recent discovery of microRNAs (miRNAs) has provided a novel mechanism for the tumorigenesis. In the present study, we explored the expression and function of miR-187 in non-small-cell lung cancer (NSCLC). Quantitative real-time PCR analysis showed that miR-187 was up-regulated in NSCLC specimens and cultured cancer cells. In vitro studies demonstrated that overexpression of miR-187 mimics enhanced cell proliferation and invasion. Mechanistically, the targets of miR-187 were predicted by bioinformatics tools. Luciferase reporter assays and western blot further revealed that the phosphatase and tensin homolog (PTEN) gene, a tumor suppressor, was suppressed by miR-187. As a result, overexpression of miR-187 mimics led to an enhanced activation of AKT signaling. In agreement, restoration of PTEN expression or inhibition of AKT activity by its antagonist in lung cancer cells largely attenuated the oncogenic roles of miR-187. Therefore, our results suggest that miR-187 promotes NSCLC progression by directly targeting PTEN and may serve as a potential therapeutic target for cancer therapy.

Supplementary Methods from Mir-205 Targets PTEN and PHLPP2 to Augment AKT Signaling and Drive Malignant Phenotypes in Non–Small Cell Lung Cancer

Supplementary Methods from MEK Inhibition Modulates Cytokine Response to Mediate Therapeutic Efficacy in Lung Cancer

Supplementary Table 2 from Proteomic Profiling Identifies Dysregulated Pathways in Small Cell Lung Cancer and Novel Therapeutic Targets Including PARP1

Supplementary Table 7 from Proteomic Profiling Identifies Dysregulated Pathways in Small Cell Lung Cancer and Novel Therapeutic Targets Including PARP1

Supplementary Materials and Methods from Loss of SNAIL Regulated Mir-128-2 on Chromosome 3p22.3 Targets Multiple Stem Cell Factors to Promote Transformation of Mammary Epithelial Cells

Supplementary Figure 3 from Proteomic Profiling Identifies Dysregulated Pathways in Small Cell Lung Cancer and Novel Therapeutic Targets Including PARP1

Supplementary Methods from the CRTC1-NEDD9 Signaling Axis Mediates Lung Cancer Progression Caused by LKB1 Loss

Microrna-187 Inhibits Pten Expression And Promotes Cell Proliferation In Non-Small-Cell Lung Cancer

Supplementary Materials and Methods and Supplementary Figure Legends from Mir200c Attenuates P-gp–Mediated MDR and Metastasis by Targeting JNK2/c-Jun Signaling Pathway in Colorectal Cancer

Supplemental Materials and Methods from KRAS/NF-κB/YY1/miR-489 Signaling Axis Controls Pancreatic Cancer Metastasis

Supplementary Materials and Methods from LINC00869 Promotes Hepatocellular Carcinoma Metastasis Via Protrusion Formation

Supplementary Materials and Methods from Lysine-Specific Demethylase 1 Mediates AKT Activity and Promotes Epithelial-to-Mesenchymal Transition in &Lt;i>pik3ca</i>-Mutant Colorectal Cancer

Supplementary Materials and Methods, Figure Legends from miR-30-5p Functions as a Tumor Suppressor and Novel Therapeutic Tool by Targeting the Oncogenic Wnt/β-Catenin/BCL9 Pathway

Supplementary Materials and Methods from DNMT1–MicroRNA126 Epigenetic Circuit Contributes to Esophageal Squamous Cell Carcinoma Growth via ADAM9–EGFR–AKT Signaling

Supplemental Methods from Multikinase Inhibitor CT-707 Targets Liver Cancer by Interrupting the Hypoxia-Activated IGF-1R–YAP Axis

Supplementary Data from Microrna-224 Promotes Cell Proliferation and Tumor Growth in Human Colorectal Cancer by Repressing PHLPP1 and PHLPP2

Supplementary Tables 1 - 3 from Pathway-Based Serum microRNA Profiling and Survival in Patients with Advanced Stage Non–Small Cell Lung Cancer

Supplementary Figures 1-6, Tables 1-15, Methods from Epigenetic Silencing Mediated Through Activated PI3K/AKT Signaling in Breast Cancer

Supplementary Tables 1 Through 4 from Mir200c Attenuates P-gp–Mediated MDR and Metastasis by Targeting JNK2/c-Jun Signaling Pathway in Colorectal Cancer

Supplementary Figure 2 from Identification of Mir-133B and RB1CC1 As Independent Predictors for Biochemical Recurrence and Potential Therapeutic Targets for Prostate Cancer